Quick Takeaways
- TANG CAPITAL MANAGEMENT LLC filed SCHEDULE 13G/A for Crescent Biopharma, Inc. Ordinary Shares, $0.001 par value per share (CBIO).
- Disclosed ownership: 4.2%.
- Date of event: 31 Mar 2026.
Quoteable Key Fact
"TANG CAPITAL MANAGEMENT LLC disclosed 4.2% ownership in Crescent Biopharma, Inc. Ordinary Shares, $0.001 par value per share (CBIO) on 31 Mar 2026."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| TANG CAPITAL MANAGEMENT, LLC | 4.2% | 1,160,000 | 0 | 1,160,000 | /s/ Kevin Tang | Manager | |
| KEVIN TANG | 4.2% | 1,160,000 | 0 | 1,160,000 | /s/ Kevin Tang | Self | |
| TANG CAPITAL PARTNERS, LP | 2.2% | 616,477 | 0 | 616,477 | /s/ Kevin Tang | Manager, Tang Capital Management, LLC, General Partner | |
| TANG CAPITAL PARTNERS INTERNATIONAL, LP | 1.6% | 451,619 | 0 | 451,619 | /s/ Kevin Tang | Manager, Tang Capital Management, LLC, General Partner | |
| TANG CAPITAL PARTNERS III, INC | 0.33% | 91,904 | 0 | 91,904 | /s/ Kevin Tang | Chief Executive Officer | |
| TANG CAPITAL PARTNERS IV, INC | 0% | 0 | 0 | 0 | /s/ Kevin Tang | Chief Executive Officer |